The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms

British Journal of Ophthalmology

Volumn 93, Issue 3, 2009, Pages 379-382

  Liu, J ^a   Colville, D ^a   Wang, Y Y ^a   Baird, P N ^b   Guymer, R H ^b   Savige, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CENTRE FOR EYE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H;

ADOLESCENT; ADULT; AGED; ALLELE; ALPORT SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DNA POLYMORPHISM; DOT AND FLECK RETINOPATHY; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR; SEX DIFFERENCE; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHILD; COMPLEMENT FACTOR H; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEPHRITIS, HEREDITARY; PHENOTYPE; POLYMORPHISM, GENETIC; RETINAL DEGENERATION; RETINAL DRUSEN; YOUNG ADULT;

EID: 61749099716     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.143388     Document Type: Article

References (28)

1. Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000;58:925-43.
2. Gubler M, Levy M, Broyer M, et al. Alport's syndrome. A report of 58 cases and a review of the literature. Am J Med 1981;70:493-505.
3. Purriel P, Drets M, Pascale E, et al. Familial hereditary nephropathy (Alport's syndrome). Am J Med 1970;49:753-73.
4. Govan JA. Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? Br J Ophthalmol 1983;67:493-503.
5. Feingold J, Bois E, Chompret A, et al. Genetic heterogeneity of Alport syndrome. Kidney Int 1985;27:672-7.
6. Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A collagen gene in Alport syndrome. Science 1990;248:1224-7.
7. Yoshioka K, Hino S, Takemura T, et al. Type IV collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 1994;44:986-96.
8. Jais JP, Knebelmann B, Giatras I, et al.2000. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000;11:649-57.
9. Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol 2003;14:2603-10.
10. Colville D, Savige JA. Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet 1997;18:161-73.
11. Shaw EA, Colville D, Wang YY, et al. Characterisation of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Neph Dial Transplant 2007;22:104-8.
12. Duvall-Young J, Macdonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol 1989;73:297-302.
13. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes to age-related macular degeneration. PNAS 2005;102:7227-32.
14. Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 2006;38:1049-54.
15. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, et al. Heterozygous and homozygous factor H deficiencies associated with haemolytic uremic syndrome or membranoproliferative glomerulonephritis. Report and genetic analysis of 16 cases. J Am Soc Nephrol 2004;15:787-95.
16. Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. PNAS 2006;103:17456-61.
17. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007;297:1793-800.
18. Ross RJ, Verma V, Rosenberg KI, et al. Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthamol 2007;2:443-57.
19. Kaur I, Hussain A, Hussain N, et al. Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci 2006;47:3729-35.
20. Baird PN, Islam FMA, Richardson AJ, et al. Analysis of the Y402H variant of the Complement Factor H gene in age-related macular degeneration. Invest Ophthalmol Vis Sci 2006;47:4194-8.
21. Gehrs KM, Pollock SC, Zilkha G. Clinical features and pathogenesis of Alport retinopathy. Retina 1995;15:305-11.
22. Perrin D, Jungers P, Grunfeld JP, et al. Perimacular changes in Alport's syndrome. Clin Nephrol 1980;13:163-7.
23. Gross O, Netzer K-O, Lambrecht R, et al. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant 2002;17:1218-27.
24. Pajari H, Setala K, Heiskari N, et al. Ocular findings in 34 patients with Alport syndrome: correlation of the findings to mutations in COL4A5 gene. Acta Ophthalmol Scand 1999;77:214-17.
25. Rumpelt HJ, Langer KH, Scharer K, et al. Split and extremely thin glomerular basement membranes in hereditary nephritis (Alport's syndrome). Virchow's Arch A Path Anat Histol 1974;364:225-33.
26. Arnold W. Uberlegungen zur pathogenese des cochleo-renalen syndroms. Acta Otolaryngol 1980;89:330-41.
27. Streeten BW, Robinson MR, Wallace R, et al. Lens capsule in Alport's syndrome. Arch Ophthalmol 1987;105:1693-7.
28. Hood J, Savige JA, Dowling J, et al. Basement membrane abnormalities in autosomal dominant Alport syndrome. Am J Kidney Dis 2000;113:455-7.